MedPath

Effects of Prednisolone and Pentoxifylline on the Regulation of Urea Synthesis in Alcoholic Hepatitis

Completed
Conditions
Alcoholic Hepatitis
Registration Number
NCT01245257
Lead Sponsor
University of Aarhus
Brief Summary

Loss of total mass of muscles (catabolism) is a serious clinical problem in patients with alcoholic hepatitis. The liver might play an important role in this stress-catabolism by increasing the production of urea during the inflammatory process.

The purpose of this study is to examine the regulation of urea synthesis in patients with alcoholic hepatitis and to study the effect of the anti-inflammatory drugs prednisolone and pentoxifylline on this regulation.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Alcoholic hepatitis (alcohol intake (> 40g/day in 6 months), bilirubin > 80 μmol/l)
Read More
Exclusion Criteria
  • Severe bacterial infections
  • Other chronical inflammatory diseases
  • Cancer
  • Other catabolic diseases
  • Treatment with prednisolone or pentoxifylline within the last 8 weeks
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Functional Hepatic Nitrogen ClearanceAt inclusion, after approximately 3 month and if severe alcoholic hepatitis also after 14 days medical treatment
Secondary Outcome Measures
NameTimeMethod
Clinical and biochemical measures of inflammationAt inclusion, after approximately 3 month and if severe alcoholic hepatitis also after 14 days medical treatment

Trial Locations

Locations (1)

Department of Medicine V, Aarhus University Hospital

🇩🇰

Aarhus, Denmark

© Copyright 2025. All Rights Reserved by MedPath